Kathleen Rickard
Chief Tech/Sci/R&D Officer en VERONA PHARMA PLC .
Fortuna: 17 M $ al 31/03/2024
Perfil
Kathleen Rickard is currently the Chief Medical Officer at Verona Pharma Plc since 2019.
Prior to this, she worked at Aerocrine AB from 2011 to 2019 as the Chief Medical & Compliance Officer.
She also worked at GSK Plc as the VP-Clinical Development & Medical Affairs.
Dr. Rickard holds a doctorate degree from Hahnemann University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VERONA PHARMA PLC
1.80% | 05/02/2024 | 8 656 336 ( 1.80% ) | 17 M $ | 31/03/2024 |
Cargos activos de Kathleen Rickard
| Empresas | Cargo | Inicio |
|---|---|---|
| VERONA PHARMA PLC | Chief Tech/Sci/R&D Officer | 01/02/2019 |
Antiguos cargos conocidos de Kathleen Rickard.
| Empresas | Cargo | Fin |
|---|---|---|
| AEROCRINE AB | Compliance Officer | 01/01/2019 |
| GSK PLC | Corporate Officer/Principal | - |
Formación de Kathleen Rickard.
| Hahnemann University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GSK PLC | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aerocrine AB
 Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Aerocrine AB operates as a specialty pharmaceutical company focused on respiratory disease. The company was founded by Lars E. Gustafsson, Jon Lundberg, Kjell Alving, and Eddie Weitzberg in November 1997 and is headquartered in Uppsala, Sweden. | Electronic Technology |
- Bolsa de valores
- Insiders
- Kathleen Rickard
